Advisory Board Member

Professor J.-Matthias Graf von der Schulenburg

Matthias joined NDA in 2010, he's a leading expert in pricing and reimbursement with a special focus on Germany and also specialises in health economic evaluation, quality of life research and risk assessment and evaluation.

Key Areas Of Expertise
  • Health economics
  • Health technology assessment (HTA)
  • Quality of life (QoL) and outcome research
  • Modelling and routine data analysis
  • Pricing and Reimbursement
  • Risk and Insurance, including health insurance
Before Joining The NDA Advisory Board

Matthias currently teaches risk and insurance and health economics at Leibniz University in Hannover, Germany; Director of the Institute for Risk and Insurance and for the Competence Center for Risk and Insurance, Hannover; Leads the Center for Health Economics Research Hannover; Editor in chief of the European Journal of Health Economics, Health Economics Review and the Journal for Insurance Science.

Recent Publications

Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception? The European Journal of Health Economics, 19 (2018), 821–830  

An Urban Crisis Management System for Critical Infrastructures - Participation Possibilities for Insurance Companies, The Geneva Papers on Risk and Insurance - Issues and Practice, 4 (2017), 633–656

German Value Set for the EQ-5D-5L, PharmacoEconomics, 36 (2018), 663-674

Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare, The European Journal of Health Economics, 20 (2019), 427-438

Affirmative and silent cyber-coverage in traditional insurance policies: Qualitative con-tent analysis of selected insurance products from the German insurance market, The Geneva Papers on Risk and Insurance – Issues and Practice 45 (2020), 657–689  

Professor J.-Matthias Graf von der Schulenburg

Stay up to date

Contact us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World